Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Executive Committee（as of April 2020）
The Executive Committee discusses important matters of management across Astellas. It is chaired by the Representative Director, President and CEO. Extended members include the officers responsible for research, development and pharmaceutical technology capabilities together with the officers responsible for each commercial region, and these members participate in any necessary discussions at the request of the chairman.
Standing Members
| Representative Director, President and Chief Executive Officer (CEO) |
Kenji Yasukawa, Ph.D. |
| Representative Director, Corporate Executive Vice President, Chief Strategy Officer (CStO) and Chief Financial Officer (CFO) |
Naoki Okamura |
| Chief Administrative Officer (CAO) and Chief Ethics & Compliance Officer (CECO) |
Fumiaki Sakurai |
| Chief Medical Officer (CMO) | Bernhardt Zeiher, M.D. |
| Chief Commercial Officer (CCO) | Yukio Matsui |
| General Counsel (GC) | Catherine Levitt |
Extended Members
| President, Drug Discovery Research | Akihiko Iwai |
| President, Pharmaceutical Technology | Hideki Shima |
| President, Development | Steven Benner |
| President, Established Markets Commercial | Dirk Kosche |
| President, Greater China Commercial | Hiroshi Hamaguchi |
| President, International Commercial | Claus Zieler |
| President, Japan Commercial | Yasuhiro Tsutsui |
| President, US Commercial | Percival Barretto-Ko |
Group Management Structure (As of April 1, 2020)
